EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Symmetric vaccine efficacy

Lucy D'Agostino McGowan iD, Sarah C Lotspeich iD, Michael G Hudgens

Biometrics · 01.07.2026 · 82 (3)

DOI: 10.1093/biomtc/ujag141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrics, online erschienen am 11.08.2026. Verfasst von Lucy D'Agostino McGowan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistical Sciences, Wake Forest University, Winston-Salem, NC 27106, United States. Hauptthemen laut MEDLINE: Vaccine Efficacy, Models, Statistical. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional measures of vaccine efficacy (VE) are inherently asymmetric, constrained above by 1 but unbounded below. As a result, VE estimates and corresponding confidence intervals (CIs) can extend far below zero, making interpretation difficult and potentially obscuring whether the apparent effect reflects true harm or simply statistical uncertainty. The proposed symmetric vaccine efficacy (SVE) is a bounded and interpretable alternative to VE that maintains desirable statistical properties while resolving these asymmetries. SVE is defined as a symmetric transformation of infection risks, with possible values within $[-1, 1]$, providing a common scale for both beneficial and harmful vaccine effects. This paper describes the relationship between SVE and traditional VE, considers inference about SVE, and illustrates the utility of the proposed measure by reanalyzing data from a randomized trial of a candidate HIV vaccine. Open-source tools for computing estimates of SVE and corresponding CIs are available in R through the sve package.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine EfficacyModels, StatisticalHumansAIDS VaccinesHIV InfectionsRandomized Controlled Trials as TopicVaccinationVaccinesBiometryComputer Simulation

Stichwörter der Autor:innen

communicationinfectious diseasepublic healthrelative risksymmetric metricsvaccination

Substanzen

AIDS VaccinesVaccines

Autor:innen und Institutionen

  • Department of Statistical Sciences, Wake Forest University, Winston-Salem, NC 27106, United States.
  • Department of Biostatistics University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.

ORCID-Profile: Lucy D'Agostino McGowan, Sarah C Lotspeich

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

D'Agostino McGowan, L., Lotspeich, S. C., & Hudgens, M. G. (2026). Symmetric vaccine efficacy. Biometrics, 82(3). https://doi.org/10.1093/biomtc/ujag141

Vancouver

D'Agostino McGowan L, Lotspeich SC, Hudgens MG. Symmetric vaccine efficacy. Biometrics. 2026;82(3). doi:10.1093/biomtc/ujag141

BibTeX
@article{DAgostinoMcGowan2026,
  author = {D'Agostino McGowan, Lucy and Lotspeich, Sarah C and Hudgens, Michael G},
  title = {Symmetric vaccine efficacy},
  journal = {Biometrics},
  year = {2026},
  volume = {82},
  number = {3},
  doi = {10.1093/biomtc/ujag141}
}
Kostenlos starten →